Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -453,897 | -366,286 | -269,722 | -28,597 | -479,743 |
| Depreciation Amortization | -9,053 | -57 | 34,867 | 42,294 | 31,936 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 341,729 |
| Accounts receivable | 5,590 | -72,059 | 36,358 | 14,308 | -13,170 |
| Accounts payable and accrued liabilities | 15,990 | 8,119 | 1,094 | -6,000 | -2,755 |
| Other Working Capital | -209,390 | -77,260 | 7,571 | -113,818 | -73,555 |
| Other Operating Activity | 149,813 | 200,030 | -84,538 | 122,612 | 231,450 |
| Operating Cash Flow | $-500,947 | $-307,513 | $-274,370 | $30,799 | $35,892 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,686 | -186,138 | -496,620 | 219,992 | 315,525 |
| PPE Investments | -45,280 | -23,783 | 238,362 | -11,955 | -35,120 |
| Purchase Of Investment | N/A | N/A | N/A | -7,185 | N/A |
| Purchase Sale Intangibles | -5,061 | -4,206 | -4,378 | -5,946 | -5,928 |
| Other Investing Activity | -5,061 | -4,206 | -4,378 | -5,946 | -5,928 |
| Investing Cash Flow | $-134,027 | $-214,127 | $-262,636 | $194,906 | $274,477 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 575,000 | N/A | 632,500 | N/A |
| Debt Repayment | -44,671 | -488,103 | -50,686 | -455,550 | 0 |
| Common Stock Issued | 522,729 | 49,442 | 6,373 | 101,317 | 52,036 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -90,548 |
| Other Financing Activity | 0 | 507,743 | -10,982 | -32,334 | -558,097 |
| Financing Cash Flow | $478,058 | $644,082 | $-55,295 | $245,933 | $-596,609 |
| Exchange Rate Effect | -273 | 352 | -418 | -111 | 617 |
| Beginning Cash Position | 399,266 | 276,472 | 869,191 | 397,664 | 683,287 |
| End Cash Position | 242,077 | 399,266 | 276,472 | 869,191 | 397,664 |
| Net Cash Flow | $-157,189 | $122,794 | $-592,719 | $471,527 | $-285,623 |
| Free Cash Flow | |||||
| Operating Cash Flow | -500,947 | -307,513 | -274,370 | 30,799 | 35,892 |
| Capital Expenditure | -45,280 | -23,805 | -15,721 | -11,955 | -35,120 |
| Free Cash Flow | -546,227 | -331,318 | -290,091 | 18,844 | 772 |